APOE Genotypes and Dementia Risk: Mechanisms and Clinical Implications
סדרה בארכיון ("עדכון לא פעיל" status)
When? This feed was archived on December 23, 2024 10:37 (). Last successful fetch was on November 08, 2024 17:36 ()
Why? עדכון לא פעיל status. השרתים שלנו לא הצליחו לאחזר פודקאסט חוקי לזמן ממושך.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 446422813 series 3609751
STUDIES:
Laws SM, Hone E, Gandy S, Martins RN. Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription. Journal of neurochemistry. 2003 Mar;84(6):1215-36.
Roses AD, Saunders AM. APOE is a major susceptibility gene for Alzheimer's disease. Current opinion in biotechnology. 1994 Dec 1;5(6):663-7.
Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A, Pachicano M, Joe E, Nelson AR, D’Orazio LM, Buennagel DP. APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline. Nature. 2020 May 7;581(7806):71-6.
Safieh M, Korczyn AD, Michaelson DM. ApoE4: an emerging therapeutic target for Alzheimer’s disease. BMC medicine. 2019 Dec;17:1-7.
Conejero-Goldberg C, Gomar JJ, Bobes-Bascaran T, Hyde TM, Kleinman JE, Herman MM, Chen S, Davies P, Goldberg TE. APOE2 enhances neuroprotection against Alzheimer’s disease through multiple molecular mechanisms. Molecular psychiatry. 2014 Nov;19(11):1243-50.
Huang YW, Zhou B, Wernig M, Südhof TC. ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and Aβ secretion. Cell. 2017 Jan 26;168(3):427-41.
16 פרקים